Annual accounts receivable:
$296.07M-$17.30M(-5.52%)Summary
- As of today (May 23, 2025), AMED annual accounts receivable is $296.07 million, with the most recent change of -$17.30 million (-5.52%) on December 31, 2024.
- During the last 3 years, AMED annual accounts receivable has risen by +$21.11 million (+7.68%).
- AMED annual accounts receivable is now -5.52% below its all-time high of $313.37 million, reached on December 31, 2023.
Performance
AMED Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$319.64M+$23.56M(+7.96%)Summary
- As of today (May 23, 2025), AMED quarterly accounts receivable is $319.64 million, with the most recent change of +$23.56 million (+7.96%) on March 31, 2025.
- Over the past year, AMED quarterly accounts receivable has dropped by -$39.72 million (-11.05%).
- AMED quarterly accounts receivable is now -11.05% below its all-time high of $359.36 million, reached on March 31, 2024.
Performance
AMED Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMED Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -11.1% |
| 3 y3 years | +7.7% | +8.9% |
| 5 y5 years | +24.6% | +19.0% |
AMED Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.5% | +7.7% | -11.1% | +14.7% |
| 5 y | 5-year | -5.5% | +24.6% | -11.1% | +28.4% |
| alltime | all time | -5.5% | +4367.0% | -11.1% | +7156.3% |
AMED Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $319.64M(+8.0%) |
| Dec 2024 | $296.07M(-5.5%) | $296.07M(-1.7%) |
| Sep 2024 | - | $301.05M(-15.7%) |
| Jun 2024 | - | $356.91M(-0.7%) |
| Mar 2024 | - | $359.36M(+14.7%) |
| Dec 2023 | $313.37M(+5.6%) | $313.37M(-1.9%) |
| Sep 2023 | - | $319.58M(+14.6%) |
| Jun 2023 | - | $278.79M(-5.2%) |
| Mar 2023 | - | $294.12M(-0.9%) |
| Dec 2022 | $296.79M(+7.9%) | $296.79M(-1.9%) |
| Sep 2022 | - | $302.47M(-1.0%) |
| Jun 2022 | - | $305.41M(+4.0%) |
| Mar 2022 | - | $293.58M(+6.8%) |
| Dec 2021 | $274.96M(+7.8%) | $274.96M(+0.1%) |
| Sep 2021 | - | $274.57M(-1.3%) |
| Jun 2021 | - | $278.22M(+0.9%) |
| Mar 2021 | - | $275.63M(+8.0%) |
| Dec 2020 | $255.15M(+7.4%) | $255.15M(+1.7%) |
| Sep 2020 | - | $250.78M(+0.7%) |
| Jun 2020 | - | $249.03M(-7.3%) |
| Mar 2020 | - | $268.55M(+13.0%) |
| Dec 2019 | $237.60M(+25.7%) | $237.60M(-6.7%) |
| Sep 2019 | - | $254.70M(+6.3%) |
| Jun 2019 | - | $239.67M(+1.4%) |
| Mar 2019 | - | $236.44M(+25.1%) |
| Dec 2018 | $188.97M(-6.1%) | $188.97M(-3.1%) |
| Sep 2018 | - | $195.03M(-1.3%) |
| Jun 2018 | - | $197.59M(+2.4%) |
| Mar 2018 | - | $192.94M(-4.1%) |
| Dec 2017 | $201.20M(+21.2%) | $201.20M(+13.4%) |
| Sep 2017 | - | $177.40M(+2.3%) |
| Jun 2017 | - | $173.39M(+0.4%) |
| Mar 2017 | - | $172.71M(+4.0%) |
| Dec 2016 | $166.06M(+32.8%) | $166.06M(+2.2%) |
| Sep 2016 | - | $162.50M(+6.8%) |
| Jun 2016 | - | $152.21M(-1.1%) |
| Mar 2016 | - | $153.86M(+23.1%) |
| Dec 2015 | $125.01M(+25.9%) | $125.01M(+2.7%) |
| Sep 2015 | - | $121.74M(+10.2%) |
| Jun 2015 | - | $110.45M(-0.2%) |
| Mar 2015 | - | $110.65M(+11.4%) |
| Dec 2014 | $99.33M(-10.6%) | $99.33M(-3.4%) |
| Sep 2014 | - | $102.86M(-7.3%) |
| Jun 2014 | - | $110.93M(-3.8%) |
| Mar 2014 | - | $115.35M(+3.8%) |
| Dec 2013 | $111.13M(-34.3%) | $111.13M(-0.0%) |
| Sep 2013 | - | $111.15M(-10.9%) |
| Jun 2013 | - | $124.77M(-13.8%) |
| Mar 2013 | - | $144.66M(-14.5%) |
| Dec 2012 | $169.17M | $169.17M(+3.5%) |
| Sep 2012 | - | $163.46M(+0.2%) |
| Jun 2012 | - | $163.16M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $161.83M(+9.3%) |
| Dec 2011 | $148.06M(+4.6%) | $148.06M(-2.1%) |
| Sep 2011 | - | $151.21M(-1.3%) |
| Jun 2011 | - | $153.27M(+8.0%) |
| Mar 2011 | - | $141.92M(+0.3%) |
| Dec 2010 | $141.55M(-5.8%) | $141.55M(-6.8%) |
| Jun 2010 | - | $151.85M(+0.9%) |
| Mar 2010 | - | $150.57M(+0.2%) |
| Dec 2009 | $150.27M(-14.5%) | $150.27M(+6.6%) |
| Sep 2009 | - | $141.01M(-8.6%) |
| Jun 2009 | - | $154.28M(-0.1%) |
| Mar 2009 | - | $154.37M(-12.1%) |
| Dec 2008 | $175.70M(+82.4%) | $175.70M(-2.3%) |
| Sep 2008 | - | $179.77M(+11.1%) |
| Jun 2008 | - | $161.86M(+12.4%) |
| Mar 2008 | - | $144.07M(+49.6%) |
| Dec 2007 | $96.31M(+28.5%) | $96.31M(+11.3%) |
| Sep 2007 | - | $86.55M(+15.4%) |
| Jun 2007 | - | $75.03M(+10.5%) |
| Mar 2007 | - | $67.93M(-9.3%) |
| Dec 2006 | $74.93M(+10.0%) | $74.93M(-7.6%) |
| Sep 2006 | - | $81.11M(+27.1%) |
| Jun 2006 | - | $63.81M(-5.3%) |
| Mar 2006 | - | $67.40M(-1.1%) |
| Dec 2005 | $68.14M(+178.4%) | $68.14M(+15.1%) |
| Sep 2005 | - | $59.21M(+60.1%) |
| Jun 2005 | - | $36.99M(+48.9%) |
| Mar 2005 | - | $24.85M(+1.5%) |
| Dec 2004 | $24.48M(+61.2%) | $24.48M(+34.0%) |
| Sep 2004 | - | $18.27M(-7.9%) |
| Jun 2004 | - | $19.84M(+33.2%) |
| Mar 2004 | - | $14.89M(-1.9%) |
| Dec 2003 | $15.19M(+7.7%) | $15.19M(+31.3%) |
| Sep 2003 | - | $11.57M(+22.7%) |
| Jun 2003 | - | $9.42M(-7.9%) |
| Mar 2003 | - | $10.23M(-27.5%) |
| Dec 2002 | $14.10M(-40.5%) | $14.10M(-5.2%) |
| Sep 2002 | - | $14.88M(-1.5%) |
| Jun 2002 | - | $15.11M(+182.6%) |
| Mar 2002 | - | $5.35M(-77.4%) |
| Dec 2001 | $23.68M(+257.3%) | $23.68M(+125.2%) |
| Sep 2001 | - | $10.52M(+138.8%) |
| Jun 2001 | - | $4.41M(-54.8%) |
| Mar 2001 | - | $9.75M(+47.2%) |
| Dec 2000 | $6.63M(-52.5%) | $6.63M(-44.2%) |
| Sep 2000 | - | $11.87M(-2.3%) |
| Jun 2000 | - | $12.15M(+20.4%) |
| Mar 2000 | - | $10.10M(+35.4%) |
| Dec 1999 | $13.94M(+87.0%) | - |
| Dec 1998 | $7.46M(-22.6%) | $7.46M(-22.6%) |
| Dec 1997 | $9.63M(+16.4%) | $9.63M(+16.4%) |
| Dec 1996 | $8.27M | $8.27M |
FAQ
- What is Amedisys annual accounts receivable?
- What is the all time high annual accounts receivable for Amedisys?
- What is Amedisys annual accounts receivable year-on-year change?
- What is Amedisys quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amedisys?
- What is Amedisys quarterly accounts receivable year-on-year change?
What is Amedisys annual accounts receivable?
The current annual accounts receivable of AMED is $296.07M
What is the all time high annual accounts receivable for Amedisys?
Amedisys all-time high annual accounts receivable is $313.37M
What is Amedisys annual accounts receivable year-on-year change?
Over the past year, AMED annual accounts receivable has changed by -$17.30M (-5.52%)
What is Amedisys quarterly accounts receivable?
The current quarterly accounts receivable of AMED is $319.64M
What is the all time high quarterly accounts receivable for Amedisys?
Amedisys all-time high quarterly accounts receivable is $359.36M
What is Amedisys quarterly accounts receivable year-on-year change?
Over the past year, AMED quarterly accounts receivable has changed by -$39.72M (-11.05%)